Since a surprise decision by Australia's drug regulator to approve the use of psychedelic drugs MDMA and psilocybin in treatment of mental illness, public interest has spiked. But those working in the field are calling for their concerns about the rollout to be urgently addressed. ⌘ Read more
Since a surprise decision by Australia's drug regulator to approve the use of psychedelic drugs MDMA and psilocybin in treatment of mental illness, public interest has spiked. But those working in the field are calling for their concerns about the rollout to be urgently addressed. ⌘ Read more